FTSE 100 pharma giants GSK and Astrazeneca may have escaped the worst of US President Donald Trump’s tariffs, according to a City broker. Pharmaceutical goods appear to be exempt from higher-rate tariffs introduced by President Trump in his Rose Garden ‘Liberation Day’ address on Wednesday, but there is still uncertainty about the impact on the [...]
Full ArticleFTSE 100 pharma giants GSK and Astrazeneca appear to swerve Trump tariffs
City A.M.
0 shares
1 views
You might like
Related news coverage
Trump’s plan for tariffs on drugmakers sinks FTSE 100 pharma stocks
Pharmaceutical imports became the latest target for President Donald Trump’s tariffs, sending FTSE 100 drugmakers stock into the..
City A.M.
FTSE 100 slumps as EU and China launch retaliatory tariffs against US
The FTSE 100 closed in the red on Wednesday, reversing gains made at the start of the week. The blue-chip index was off 2.9 per..
City A.M.